FALLS CHURCH, Va., Aug. 24 /PRNewswire/ -- FDAnews announced today a
special two-day, hands-on workshop: THE OFF-LABEL CRISIS WORKSHOP: IDENTIFY
AND ELIMINATE RISKY PRACTICES BEFORE IT'S TOO LATE
This workshop is scheduled Sept. 20-21, 2005 at the Loews Philadelphia
Hotel in Philadelphia, PA.
It's a proactive way to secure your company before bad practices lead to
investigations, prosecutions and lost profit. Learn from the only interactive
two-day workshop exclusively designed to help you tackle this costly and
Even drug and device companies that haven't intentionally violated the law
are being singled out for prosecution! This is NOT the time to be complacent!
Register today for THE OFF-LABEL CRISIS WORKSHOP. Let expert litigators
and compliance officers from McGuireWoods, Purdue Pharma and Deloitte help you
identify and minimize your exposure.
The workshop will focus on the emerging crisis drug and device firms face
as federal and state prosecutors crack down on off-label promotion practices.
WORKSHOP ATTENDEES WILL LEARN
-- Key factors that trigger off-label promotion risks
-- What you must know about federal and state initiatives in off-label
-- What the Federal False Claims Act really means to your operations
-- How to structure effective internal reviews
-- How to respond to government inquiries and investigations
-- How to minimize penalties for violations -- both civil and criminal
-- Best methods for dealing with whistle-blowers and wrongful discharge
-- Proven strategies for continuous monitoring and improvement
Registration: $1,795. Tuition includes two days of training and
interactive sessions, training materials (presentation slides and reference
material), continental breakfast and lunch each day, and first evening
Phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Fax: +1 (703) 538-7676
PRESENTED BY FDANEWS
FDAnews is the premier provider of global regulatory, legislative and
business news and information for professionals in industries regulated by the
FDA and the European Medicines Agency. Pharmaceutical and medical device
professionals rely on FDAnews' conferences, print and electronic newsletters,
and books to stay in compliance with international standards and FDA's complex
and ever-changing regulations.
CONTACT: Jeff Grizzel
300 N Washington St Ste 200
Falls Church VA USA 22046